Budd-Chiari syndrome in urology: Impact on nephrectomy for advanced renal cell carcinoma

Samir P. Shirodkar, Mark S. Soloway, Gaetano Ciancio

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives : Budd-Chiari syndrome (BCS) is a poorly understood entity in urology. It results from obstruction of the hepatic veins and the subsequent complications. It has been infrequently reported to be secondary to hepatic venous obstruction from invasion by an inferior vena cava (IVC) tumor thrombus in renal cell carcinoma (RCC). We report the largest known series of patients with RCC and BCS. Patients and Methods : Ten patients presented to a tertiary hospital with locally advanced RCC with IVC tumor thrombus. All were evaluated and had clinical or radiographic evidence of BCS. All underwent nephrectomy, IVC thrombectomy or ligation, and tumor removal from the hepatic veins. The perioperative and pathological factors were measured. These included estimated blood loss (EBL) and transfusions. Inpatient factors including duration of intubation, length of intensive care unit (ICU) stay, and overall length of stay (LOS) were recorded. The tumor-free status was evaluated. Results : The average age was 59 years. No intraoperative deaths occurred. Two intraoperative complications were noted. The mean EBL was 4244 cc; mean surgery length was 8 hours 12 minutes; and the mean ICU stay was nine days. The overall LOS averaged 13.25 days. One patient died postoperatively of sepsis and multisystem organ failure. One patient required reoperation for an abdominal wall hematoma caused by subcutaneous enoxaparin administration. Average follow-up was 28 months. Five patients are alive with no evidence of disease. Conclusions : Budd-Chiari syndrome is a rare entity in urology, with a potential for significant morbidity and mortality. Surgical excision of the primary tumor along with thrombectomy results in alleviation of BCS and improvement in the patient.

Original languageEnglish
Pages (from-to)351-356
Number of pages6
JournalIndian Journal of Urology
Volume27
Issue number3
DOIs
StatePublished - Jul 1 2011

Fingerprint

Budd-Chiari Syndrome
Urology
Nephrectomy
Renal Cell Carcinoma
Inferior Vena Cava
Thrombectomy
Hepatic Veins
Neoplasms
Intensive Care Units
Length of Stay
Thrombosis
Enoxaparin
Intraoperative Complications
Abdominal Wall
Reoperation
Intubation
Tertiary Care Centers
Blood Transfusion
Hematoma
Ligation

Keywords

  • Budd-Chiari syndrome
  • hepatic vein thrombus
  • inferior vena cava thrombus
  • renal cell carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Budd-Chiari syndrome in urology : Impact on nephrectomy for advanced renal cell carcinoma. / Shirodkar, Samir P.; Soloway, Mark S.; Ciancio, Gaetano.

In: Indian Journal of Urology, Vol. 27, No. 3, 01.07.2011, p. 351-356.

Research output: Contribution to journalArticle

@article{ea325abd6b644de58deff80433595b29,
title = "Budd-Chiari syndrome in urology: Impact on nephrectomy for advanced renal cell carcinoma",
abstract = "Objectives : Budd-Chiari syndrome (BCS) is a poorly understood entity in urology. It results from obstruction of the hepatic veins and the subsequent complications. It has been infrequently reported to be secondary to hepatic venous obstruction from invasion by an inferior vena cava (IVC) tumor thrombus in renal cell carcinoma (RCC). We report the largest known series of patients with RCC and BCS. Patients and Methods : Ten patients presented to a tertiary hospital with locally advanced RCC with IVC tumor thrombus. All were evaluated and had clinical or radiographic evidence of BCS. All underwent nephrectomy, IVC thrombectomy or ligation, and tumor removal from the hepatic veins. The perioperative and pathological factors were measured. These included estimated blood loss (EBL) and transfusions. Inpatient factors including duration of intubation, length of intensive care unit (ICU) stay, and overall length of stay (LOS) were recorded. The tumor-free status was evaluated. Results : The average age was 59 years. No intraoperative deaths occurred. Two intraoperative complications were noted. The mean EBL was 4244 cc; mean surgery length was 8 hours 12 minutes; and the mean ICU stay was nine days. The overall LOS averaged 13.25 days. One patient died postoperatively of sepsis and multisystem organ failure. One patient required reoperation for an abdominal wall hematoma caused by subcutaneous enoxaparin administration. Average follow-up was 28 months. Five patients are alive with no evidence of disease. Conclusions : Budd-Chiari syndrome is a rare entity in urology, with a potential for significant morbidity and mortality. Surgical excision of the primary tumor along with thrombectomy results in alleviation of BCS and improvement in the patient.",
keywords = "Budd-Chiari syndrome, hepatic vein thrombus, inferior vena cava thrombus, renal cell carcinoma",
author = "Shirodkar, {Samir P.} and Soloway, {Mark S.} and Gaetano Ciancio",
year = "2011",
month = "7",
day = "1",
doi = "10.4103/0970-1591.85439",
language = "English",
volume = "27",
pages = "351--356",
journal = "Indian Journal of Urology",
issn = "0970-1591",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - Budd-Chiari syndrome in urology

T2 - Impact on nephrectomy for advanced renal cell carcinoma

AU - Shirodkar, Samir P.

AU - Soloway, Mark S.

AU - Ciancio, Gaetano

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Objectives : Budd-Chiari syndrome (BCS) is a poorly understood entity in urology. It results from obstruction of the hepatic veins and the subsequent complications. It has been infrequently reported to be secondary to hepatic venous obstruction from invasion by an inferior vena cava (IVC) tumor thrombus in renal cell carcinoma (RCC). We report the largest known series of patients with RCC and BCS. Patients and Methods : Ten patients presented to a tertiary hospital with locally advanced RCC with IVC tumor thrombus. All were evaluated and had clinical or radiographic evidence of BCS. All underwent nephrectomy, IVC thrombectomy or ligation, and tumor removal from the hepatic veins. The perioperative and pathological factors were measured. These included estimated blood loss (EBL) and transfusions. Inpatient factors including duration of intubation, length of intensive care unit (ICU) stay, and overall length of stay (LOS) were recorded. The tumor-free status was evaluated. Results : The average age was 59 years. No intraoperative deaths occurred. Two intraoperative complications were noted. The mean EBL was 4244 cc; mean surgery length was 8 hours 12 minutes; and the mean ICU stay was nine days. The overall LOS averaged 13.25 days. One patient died postoperatively of sepsis and multisystem organ failure. One patient required reoperation for an abdominal wall hematoma caused by subcutaneous enoxaparin administration. Average follow-up was 28 months. Five patients are alive with no evidence of disease. Conclusions : Budd-Chiari syndrome is a rare entity in urology, with a potential for significant morbidity and mortality. Surgical excision of the primary tumor along with thrombectomy results in alleviation of BCS and improvement in the patient.

AB - Objectives : Budd-Chiari syndrome (BCS) is a poorly understood entity in urology. It results from obstruction of the hepatic veins and the subsequent complications. It has been infrequently reported to be secondary to hepatic venous obstruction from invasion by an inferior vena cava (IVC) tumor thrombus in renal cell carcinoma (RCC). We report the largest known series of patients with RCC and BCS. Patients and Methods : Ten patients presented to a tertiary hospital with locally advanced RCC with IVC tumor thrombus. All were evaluated and had clinical or radiographic evidence of BCS. All underwent nephrectomy, IVC thrombectomy or ligation, and tumor removal from the hepatic veins. The perioperative and pathological factors were measured. These included estimated blood loss (EBL) and transfusions. Inpatient factors including duration of intubation, length of intensive care unit (ICU) stay, and overall length of stay (LOS) were recorded. The tumor-free status was evaluated. Results : The average age was 59 years. No intraoperative deaths occurred. Two intraoperative complications were noted. The mean EBL was 4244 cc; mean surgery length was 8 hours 12 minutes; and the mean ICU stay was nine days. The overall LOS averaged 13.25 days. One patient died postoperatively of sepsis and multisystem organ failure. One patient required reoperation for an abdominal wall hematoma caused by subcutaneous enoxaparin administration. Average follow-up was 28 months. Five patients are alive with no evidence of disease. Conclusions : Budd-Chiari syndrome is a rare entity in urology, with a potential for significant morbidity and mortality. Surgical excision of the primary tumor along with thrombectomy results in alleviation of BCS and improvement in the patient.

KW - Budd-Chiari syndrome

KW - hepatic vein thrombus

KW - inferior vena cava thrombus

KW - renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=80054042875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054042875&partnerID=8YFLogxK

U2 - 10.4103/0970-1591.85439

DO - 10.4103/0970-1591.85439

M3 - Article

C2 - 22022058

AN - SCOPUS:80054042875

VL - 27

SP - 351

EP - 356

JO - Indian Journal of Urology

JF - Indian Journal of Urology

SN - 0970-1591

IS - 3

ER -